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The alteration of Reactive Oxygen Species (ROS) homeostasis plays a causal role 
in several chronic pathology such as aging and neurodegenerative diseases like 
Amyotrophic Lateral Sclerosis (ALS). Although it is recognized that axon and syn-
apses are first cellular sites of degeneration in ALS disease, controversy exists on 
whether pathological events initially begin at the NMJs and then, in a dying back 
phenomena, contribute to motor neuron degeneration. Moreover, the precise molecu-
lar mechanisms of pathology-associated deterioration in neuromuscular system have 
remained elusive (1). Here we provide evidences that muscle specific accumulation of 
SOD1G93A in the transgenic mice model MLC/SOD1G93A (2) induces mitochondria 
dysfunction and triggers NMJ dismantlement. Further, we demonstrate that treat-
ment of MLC/SOD1G93A mice with Trolox, a potent antioxidant, is sufficient to res-
cue mitochondria and NMJ defects in the MLC/SOD1G93A mice, stabilizing muscle-
nerve connection. The analysis of potential molecular mechanisms that mediate the 
toxic activity of SOD1 revealed the activation of specific Protein Kinase as a down-
stream player of NMJ dismantlement. Overall our data demonstrate that muscle spe-
cific expression of SOD1G93A mutation causes mitochondrial impairment and NMJ 
dismantlement, suggesting that muscle defects and NMJs alteration precede motor 
neuron degeneration rather than resulting from it.
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